Teratogenic study of doxycycline

Obstetrics and Gynecology

Volumn 89, Issue 4, 1997, Pages 524-528

  Czeizel, Andrew E ^a,b   Rockenbauer, Magda ^a  

^a National Institute of Hygiene Budapest   (Hungary)

^b OKI National Institute for Public Education Budapest   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG CONTRAINDICATION; DRUG SCREENING; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; DOXYCYCLINE; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 0031127095     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00005-7     Document Type: Article

References (7)

1. 1. Shepard TH. Catalog of teratogenic agents. 7th ed. Baltimore: Johns Hopkins University Press, 1992.
2. 2. Czeizel AE. Analysis of medical indications for induced abortions [Hungarian with English abstract]. Orv Hetil 1983;124:1297-302.
3. 3. Czeizel AE, Rácz J. Evaluation of drug intake during pregnancy in the Hungarian Case-Control Surveillance of Congenital Anomalies. Teratology 1990;42:505-12.
4. 4. Czeizel AE. The activities of the Hungarian Centre for Congenital Anomaly Control. World Health Stat Q 1988;41:219-27.
5. 5. Pearson PS, Hartley HO. Biometrikar tables for statisticians. Vol. I. Cambridge: Cambridge University Press, 1966.
6. 6. Cahen RL, Fave A. Absence of teratogenic effect of 6-α-deoxy-5-oxytetracycline. Fed Proc 1972;31:238.
7. 7. Delahunt CS, Jacobs RT, Stebbins RB, Rieser N. Toxicology of vibramycin. Toxicol Appl Pharmacol 1967;10:402-8.